SBI Q1 Results Review: NIM A Drag, But Asset Quality, Loan Growth Hold Up
State Bank of India's first-quarter profit beat analysts' expectations, but analysts are concerned by the operationally weak numbers of the country's largest lender.
India's largest lender's net profit surged 178.25% year-on-year to Rs 16,884.3 crore in the quarter ended June, according to an exchange filing. Net interest income, or core income, rose 24.71% to Rs 38,904.9 crore.
The bank's asset quality improved, with the gross non-performing asset ratio improving to 2.76% quarter-on-quarter and the net NPA ratio declining to 0.71% sequentially, compared with 2.78% as of March 31. Provisions for the quarter fell 43.05% year-on-year to Rs 2,501.3 crore.
However, lower NIMs and higher opex dragged core operating profit lower, according to Jefferies. The repricing of MCLR-linked loans failed to offset the pressure from increased funding costs as NIMs narrowed by 27 basis points quarter-on-quarter, the brokerage said.
The lender's fresh slippages more than doubled to Rs 7,659 crore quarter-on-quarter, compared to Rs 3,185 crore in the previous quarter.
Shares of the company was 3.70% up at Rs 577 apiece during pre-market trade on Monday.
Of the 50 analysts tracking the company, 47 maintain a 'buy', two suggest a 'hold' and one recommends a 'sell', according to Bloomberg. The average of 12-month price target given by analysts implies an upside of 25.5%.
Here is what analysts said about SBI's Q1FY24 results:
Jefferies:
Lower NIMs and higher opex dragged core operating profit to 11% growth year-on-year.
The compression of NIMs by 27 basis points quarter-on-quarter was unexpected, as repricing of MCLR-linked loans was expected to offset the pressure from increased funding costs.
SBI's CASA growth may have been boosted partly by the deposit of Rs 2,000 notes.
Clarity on the extension or change of chairman will be a key monitorable for SBI.
Maintain 'buy' with a target price of Rs 760, suggesting an upside of 29%.
Macquarie:
The lender's loan growth of 14% year-on-year was driven by retail and SME segments, whereas the corporate book was flat quarter-on-quarter.
Of the PL book, 94% is for salaried customers employed in the government sector or government companies.
Lower-than-expected loan growth and deterioration in asset quality are the key risks.
Maintain 'outperform' with a target price of Rs 720, suggesting an upside of 23.9%.
Ambit Capital:
Expect the bank to deliver a 15% loan CAGR while maintaining a steady NIM over FY23–25 owing to a high share of MCLR loans, a low credit-deposit ratio, and a changing loan mix.
Fee income was adversely impacted due to muted forex income, but non-core income was strong due to strong recoveries and investment gains.
Other opex grew 4% year-on-year due to a decline in business acquisitions and development expenses and insurance costs.
Expect asset quality trends in FY24–25 to be better than private banks due to a better-quality retail loan book. With this, the credit cost is expected to be contained at 65 bps over FY23–25E.
Maintain 'buy' with a target price of Rs 750, suggesting a potential upside of 30.8%.
Systematix Institutional Equities:
Current accounts declined 8% quarter-on-quarter due to seasonal weakness.
Return ratios in Q1 FY24 were strong, with RoA at 1.2% and RoE at 20.1%.
Xpress credit, which is mainly unsecured personal loans to salaried PSU employees, slowed below the trend growth of 6% quarter-on-quarter to 2% quarter-on-quarter and 20% year-on-year.
Estimate deposit repricing to continue along with modest asset repricing, resulting in FY24E NIMs at 12 bps below the Q1FY24 levels.
Maintain 'buy' with a target price of Rs 670, implying an upside of 16.9%.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.